Foghorn Therapeutics Inc (FHTX) Price Prediction & ForecastFHTXFoghorn Therapeutics Inc

Alphio's FHTX stock price prediction model matches the current Foghorn Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.90 (-0.17%). The 1-week path is $1.89 (-0.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Foghorn Therapeutics Inc. (FHTX) is currently not a strong buy due to significant risks overshadowing potential gains. The stock is priced at $2.13, which is close to the recent analyst price targets of $2 and $5, indicating limited upside potential. The company has faced major setbacks, including the halting of its cancer drug development, leading to a 58.96% year-to-date decline. Although the RSI is at 60.28, suggesting some momentum, the overall sentiment has shifted negatively following the announcement of workforce reductions and the cessation of key drug programs. The primary risk is the ongoing securities fraud investigation, which could further impact investor confidence and stock performance.

Foghorn Therapeutics Inc (FHTX) last closed at $1.905, losing -9.29%. These facts feed the 1-day and 1-week FHTX price prediction above.